Patents by Inventor Peter Lischka

Peter Lischka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PARAPOXVIRUS FOR CONDITIONING FOR AND TREATMENT OF CORONAVIRUS INFECTIONS
    Publication number: 20220401553
    Abstract: The present invention relates to the treatment of coronavirus infections and to preparing subjects for such an infection by administering a parapoxvirus. This treatment is to assist the immune system in combatting the virus and to thereby prevent and to ameliorate symptoms of coronavirus disease.
    Type: Application
    Filed: May 10, 2021
    Publication date: December 22, 2022
    Inventors: Daniela Paulsen, Alexander Birkmann, Peter Lischka, Tamara Pfaff, Holger Zimmermann
  • Production of dense bodies (DB) from HCMV-infected cells
    Patent number: 9458433
    Abstract: The invention relates to the production of dense bodies (DB) and to a pharmaceutical composition containing DB.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: October 4, 2016
    Assignee: AICURIS GMBH & CO. KG
    Inventors: Peter Lischka, Christian Sinzger
  • IDENTIFICATION OF AN ALTERED THERAPEUTIC SUSCEPTIBILITY TO ANTI-HCMV COMPOUNDS AND OF A RESISTANCE AGAINST ANTI-HCMV COMPOUNDS
    Publication number: 20140193802
    Abstract: The present invention relates to a method for the detection of an altered therapeutic response of a subject infected by HCMV to a treatment with a 3,4 dihydroquinazoline or N-{3-[({4-[5-(6-aminopyridin-2-yl)-1,2,4-oxadiazol-3-yl]phenyl}sulfonyl)amino]-5-fluorophenyl}-1-cyanocyclopropanecarboxamide, a method for the detection of a drug resistance of a HCMV to a 3,4-dihydroquinazoline or N-{3-[({4-[5-(6-aminopyridin-2-yl)-1,2,4-oxadiazol-3-yl]phenyl}sulfonyl)amino]-5-fluorophenyl}-1-cyanocyclopropanecarboxamide, and to a method for the detection of a mutation of a HCMV resulting in a drug resistance to a 3,4-dihydroquinazoline or N-{3-[({4-[5-(6-aminopyridin-2-yl)-1,2,4-oxadiazol-3-yl]phenyl}sulfonyl)amino]-5-fluorophenyl}-1-cyanocyclopropanecarboxamide.
    Type: Application
    Filed: July 11, 2013
    Publication date: July 10, 2014
    Inventor: Peter LISCHKA
  • PRODUCTION OF DENSE BODIES (DB) FROM HCMV-INFECTED CELLS
    Publication number: 20140178432
    Abstract: The invention relates to the production of dense bodies (DB) and to a pharmaceutical composition containing DB.
    Type: Application
    Filed: May 3, 2012
    Publication date: June 26, 2014
    Applicant: AICURIS GMBH & CO. KG
    Inventors: Peter Lischka, Christian Sinzger